Kestra Medical Technologies (Nasdaq:KMTS) announced today that it entered into a strategic collaboration with Biobeat ...

The wearable cardiac monitor and defibrillator developer Kestra Medical Technologies aims to raise about $154 million by going public on the Nasdaq, with plans to greatly scale up its commercial ...

For patients with certain cardiovascular conditions and risk factors, sudden cardiac arrest is more than a theoretical concern. But over the past 25 years, the development of various types of ...

Non-invasive wearable devices might be able to predict preterm birth by monitoring changes in maternal heart rate variability. D.M.P., S.R.J., and E.R.C. are employed by the commercial company WHOOP ...

Cardiovascular diseases remain a global health crisis, spurring an urgent demand for innovative diagnostic tools that enable early detection and effective treatment. Wearable heart sound devices ...